Clicky

Timber Pharmaceuticals, Inc.(TMBR)

Description: Timber Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases. The company's investigational therapies have proven mechanisms-of-action backed by decades of clinical experience and well-established CMC (chemistry, manufacturing and control) and safety profiles. Timber is initially focused on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis (CI), tuberous sclerosis complex (TSC), and localized scleroderma.


Keywords: Medicine Biopharmaceutical Autoimmune Disease Rare Diseases Genodermatoses Connective Tissue Diseases Scleroderma Ichthyosis Investigational Therapies Tuberous Sclerosis

Home Page: www.timberpharma.com

TMBR Technical Analysis

110 Allen Road
Basking Ridge, NJ 07920
United States
Phone: 973 314 9577


Officers

Name Title
Mr. John Koconis M.B.A. Chairman, CEO & Pres
Mr. Joseph Lucchese Exec. VP, CFO, Treasurer & Sec.
Dr. Alan Mendelsohn M.D. Exec. VP & Chief Medical Officer

Exchange: NYSE MKT

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0.6151
Price-to-Sales TTM: 17.1859
IPO Date: 2015-06-09
Fiscal Year End: December
Full Time Employees: 5
Back to stocks